| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Pamela Tenaerts last filed a Form 4 in May 2021, as Director at SCNX. Pamela Tenaerts's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 10,867 shares of SCNX. The SCNX filings lean toward selling, a net 800 shares.
Pamela Tenaerts has 5 Form 4 filings on record from April 2020 to May 2021, all as Scienture (SCNX), 2020–2021.
The 5 reported transactions were 2 stock awards, 1 disposition back to the company, 1 open-market sale and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $4K.
The only open-market sale was 800 shares of SCNX at an average $5.30 on December 14, 2020, about $4K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | SCNX Scienture Holdings, Inc. | - | Sell | 800 | $5.30 | $4,240.00 | -8.9% |